Europe – COVID-19 treatments: Article 5(3) reviews

COVID-19 treatments being reviewed by the European Medicines Agency (EMA) under Article 5(3) of Regulation (EC) No 726/2004 to treat COVID-19.

This is intended to support national decision-making on the possible use of these medicines before a formal authorisation is issued…